Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

RTTNews | 1070 days ago
Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

(RTTNews) - Pharmaceutical company Inhibikase Therapeutics, Inc. (IKT) announced Friday that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

IkT-001Pro is a prodrug formulation of imatinib mesylate and has been developed to improve the safety of the first FDA-approved Abelson (Abl) kinase inhibitor, imatinib (marketed as Gleevec).

IkT-001Pro has the potential to be a safer alternative for patients and may improve the number of patients that reach and sustain major and/or complete cytogenetic responses in stable-phase CML.

In preclinical studies, IkT-001Pro was shown to be as much as 3.4 times safer than imatinib in non-human primates, reducing burdensome gastrointestinal side effects that occur following oral administration.

Imatinib delivered as IkT-001Pro was granted Orphan Drug Designation for stable-phase CML in September, 2018.

IkT-001Pro will be evaluated in a single ascending dose bioequivalence study and will enroll approximately 64 male and female healthy volunteers aged 25 to 55 who will receive IkT-001Pro at one of four doses.

For More Such Health News, visit rttnews.com

read more
China Manufacturing Activity Slips Into Contraction

China Manufacturing Activity Slips Into Contraction

China's factory activity contracted in July as softening new orders forced manufacturers to scale back production and staffing, purchasing managers' survey results from S&P Global showed on Friday. The manufacturing Purchasing Managers' Index fell to 49.5 in July from 50.4 in June. The latest score suggested contraction in the sector.
RTTNews | 13 minutes ago
European Economic News Preview: Eurozone Flash Inflation Data Due

European Economic News Preview: Eurozone Flash Inflation Data Due

Flash inflation and final Purchasing Managers' survey data from the euro area are the top economic news due on Friday. At 2.00 am ET, UK Nationwide house price data is due. House prices are forecast to rise 2.1 percent on a yearly basis in July, the same rate as seen in June. At 3.15 am ET, S&P Global publishes Spain's manufacturing PMI data. The index is forecast to rise to 51.7 in July.
RTTNews | 45 minutes ago
Australian Market Maintains Early Losses In Mid-market

Australian Market Maintains Early Losses In Mid-market

The Australian stock market is maintaining its early losses in mid-market moves on Friday, extending the losses in the previous session, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,700 level, with weakness across most sectors led by energy and technology stocks.
RTTNews | 3h 19min ago
Asian Markets Mixed Amid Tariff Uncertainty

Asian Markets Mixed Amid Tariff Uncertainty

Asian stock markets are trading mixed on Friday, following the broadly negative cues from Wall Street overnight, as uncertainty over US reciprocal tariffs still lingers with less than a day remaining for the crucial deadline for negotiations to reach a trade deal expires. US President Donald Trump's revised tariffs on several countries lacking deals are set to be fixed between 10 and 41 percent.
RTTNews | 3h 39min ago
Japanese Market Notably Lower

Japanese Market Notably Lower

Reversing the gains in the previous session, the Japanese market is notably lower on Friday, following the broadly negative cues from Wall Street overnight. The Nikkei 225 is falling below the 40,700 level, with weakness in financial and technology stocks partially offset by gains in exporters and automaker stocks.
RTTNews | 5h 15min ago